These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 29848323)

  • 1. Circulating levels of adipose tissue-derived inflammatory factors in elderly diabetes patients with carotid atherosclerosis: a retrospective study.
    Yang W; Li Y; Wang JY; Han R; Wang L
    Cardiovasc Diabetol; 2018 May; 17(1):75. PubMed ID: 29848323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Tsanikidis H; Vitta I; Karkos C; Karayannacos PE; Gerasimidis T; Liapis CD
    Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):75-80. PubMed ID: 19834878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
    Zhang XJ; Wang Z; Li HH; Yu L; Gao S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
    Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
    Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of adiponectin, leptin, resistin and visfatin in non-diabetics patients with hidradenitis suppurativa.
    González-López MA; Vilanova I; Ocejo-Viñals G; Arlegui R; Navarro I; Guiral S; Mata C; Pérez-Paredes MG; Portilla V; Corrales A; González-Vela MC; González-Gay MA; Blanco R; Hernández JL
    Arch Dermatol Res; 2020 Oct; 312(8):595-600. PubMed ID: 31786710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visfatin, resistin, hsCRP and insulin resistance in relation to abdominal obesity in women with rheumatoid arthritis.
    Straburzyńska-Lupa A; Nowak A; Pilaczyńska-Szcześniak Ł; Straburzyńska-Migaj E; Romanowski W; Karolkiewicz J; Sliwicka E
    Clin Exp Rheumatol; 2010; 28(1):19-24. PubMed ID: 20346233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
    Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
    Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis.
    Rho YH; Chung CP; Solus JF; Raggi P; Oeser A; Gebretsadik T; Shintani A; Stein CM
    Arthritis Rheum; 2010 May; 62(5):1259-64. PubMed ID: 20213808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity.
    Dikbas O; Tosun M; Bes C; Tonuk SB; Aksehirli OY; Soy M
    Int J Rheum Dis; 2016 Jul; 19(7):672-7. PubMed ID: 25196858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocytokines in primary antiphospholipid syndrome: potential markers of low-grade inflammation, insulin resistance and metabolic syndrome.
    Rodrigues CE; Vendramini MB; Bueno C; Bonfá E; de Carvalho JF
    Clin Exp Rheumatol; 2012; 30(6):871-8. PubMed ID: 22935544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
    Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
    Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the adipocytokines vaspin and visfatin in vascular endothelial function and insulin resistance in obese children.
    Yin C; Hu W; Wang M; Xiao Y
    BMC Endocr Disord; 2019 Nov; 19(1):127. PubMed ID: 31771561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum visfatin, resistin and IL-18 in A group of Egyptian obese diabetic and non diabetic individuals.
    Mabrouk R; Ghareeb H; Shehab A; Omar K; El-Kabarity RH; Soliman DA; Mohamed NA
    Egypt J Immunol; 2013; 20(1):1-11. PubMed ID: 23888552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum vaspin levels are positively associated with carotid atherosclerosis in a general population.
    Esaki E; Adachi H; Hirai Y; Yamagishi S; Kakuma T; Enomoto M; Fukami A; Kumagai E; Ohbu K; Obuchi A; Yoshimura A; Nakamura S; Nohara Y; Fujiyama T; Fukumoto Y; Imaizumi T
    Atherosclerosis; 2014 Mar; 233(1):248-52. PubMed ID: 24529152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA; Barakat YA
    Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy.
    Gonzalez-Gay MA; Vazquez-Rodriguez TR; Garcia-Unzueta MT; Berja A; Miranda-Filloy JA; de Matias JM; Gonzalez-Juanatey C; Llorca J
    Clin Exp Rheumatol; 2010; 28(1):56-62. PubMed ID: 20346239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparison of serum vaspin and visfatin concentrations in obese and normal weight women.
    Saboori S; Hosseinzadeh-Attar MJ; Yousefi Rad E; Hosseini M; Mirzaei K; Ahmadivand Z
    Diabetes Metab Syndr; 2015; 9(4):320-3. PubMed ID: 25470626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus.
    Akbarzadeh S; Nabipour I; Jafari SM; Movahed A; Motamed N; Assadi M; Hajian N
    Diabetes Res Clin Pract; 2012 Jan; 95(1):132-8. PubMed ID: 22024288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report.
    Cantarini L; Brucato A; Simonini G; Imazio M; Cumetti D; Cimaz R; Bacarelli MR; Muscari I; Vitale A; Lucherini OM; Galeazzi M; Fioravanti A
    Clin Exp Rheumatol; 2013; 31(2):207-12. PubMed ID: 23137677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
    Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.